The age of your parent at the onset of Alzheimer’s disease is an important risk factor that determines when the disease may strike you.
The closer a person gets to the age at which their parent exhibited the first signs of Alzheimer's, the more likely they are to have amyloid plaques. These plaques are the cause of the cognitive decline associated with the disease. The study is published in the journal JAMA Neurology. In this study involving a cohort of 101 individuals, researcher Sylvia Villeneuve (Douglas Mental Health University Institute; CIUSSS de l'Ouest-de-l'Île-de-Montréal) shows that the difference between a person's age and the age of their parent at the onset of the disease is a more important risk factor than their actual age.
‘The difference between a person's age and the age of their parent at the onset of Alzheimer's disease is a more important risk factor the disease than their actual age.’
A 60-year-old whose mother developed Alzheimer's at age 63 would be more likely to have amyloid plaques in their brain than a 70-year-old whose mother developed the disease at age 85," explains Villeneuve, an assistant professor at McGill University and a core faculty member at the McConnell Brain Imaging Centre at the Montreal Neurological Institute and Hospital (The Neuro). Her team of scientists also found that the genetic impact of Alzheimer's disease is much greater than previously thought.
"Upon examining changes in the amyloid biomarker in the cerebrospinal fluid samples from our subjects, we noticed that this link between parental age and amyloid deposits is stronger in women than in men. The link is also stronger in carriers of the ApoE4 gene, the so-called 'Alzheimer's gene'," says Villeneuve.
Towards earlier detection of the disease
The researcher and her team successfully duplicated their results in two independent groups, one, consisting of 128 individuals from a University of Washington-St. Louis cohort, the other consisting of 135 individuals from a University of Wisconsin-Madison cohort. They also reproduced their results using an imaging technique that enables one to see amyloid plaques directly in the brains of living persons.
Advertisement
Advertisement